Astrazeneca PLC (AZN) Sees Strong Trading Volume
Astrazeneca PLC (NYSE:AZN) saw unusually-strong trading volume on Thursday . Approximately 4,913,698 shares were traded during trading, an increase of 3% from the previous session’s volume of 4,763,181 shares.The stock last traded at $32.67 and had previously closed at $32.81.
A number of research analysts have weighed in on AZN shares. Argus raised Astrazeneca PLC from a “hold” rating to a “buy” rating and set a $38.00 target price for the company in a report on Monday. Bank of America Corp. reaffirmed a “buy” rating and set a $36.65 target price on shares of Astrazeneca PLC in a report on Monday, July 18th. Cantor Fitzgerald reaffirmed a “buy” rating on shares of Astrazeneca PLC in a report on Thursday, July 28th. Beaufort Securities reaffirmed a “hold” rating on shares of Astrazeneca PLC in a report on Friday, August 26th. Finally, Shore Capital reaffirmed a “hold” rating on shares of Astrazeneca PLC in a report on Tuesday, June 14th. Two analysts have rated the stock with a sell rating, eight have assigned a hold rating, eleven have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and an average target price of $36.88.
The firm has a market capitalization of $82.48 billion and a P/E ratio of 37.26. The company’s 50-day moving average price is $32.86 and its 200 day moving average price is $30.06.
Astrazeneca PLC (NYSE:AZN) last announced its earnings results on Thursday, July 28th. The company reported $0.83 EPS for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.07. The company earned $5.60 billion during the quarter, compared to analysts’ expectations of $5.56 billion. During the same quarter last year, the firm posted $1.21 EPS. Astrazeneca PLC’s revenue for the quarter was down 4.0% compared to the same quarter last year. Analysts expect that Astrazeneca PLC will post $2.97 EPS for the current year.
The firm also recently declared a dividend, which will be paid on Monday, September 12th. Investors of record on Friday, August 12th will be paid a dividend of $0.44 per share. The ex-dividend date of this dividend is Wednesday, August 10th.
AstraZeneca PLC (AstraZeneca) is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of prescription medicines, primarily for the treatment of diseases in various therapy areas, including respiratory, inflammation, autoimmune disease (RIA), cardiovascular and metabolic disease (CVMD) and oncology, as well as in infection, neuroscience and gastrointestinal areas.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.